Georg Seifert Selected Research

EPs 7630

1/2021	Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.
1/2019	Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in children with acute respiratory tract infections.
1/2018	EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georg Seifert Research Topics

Disease

15	Neoplasms (Cancer) 06/2022 - 11/2006
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2009 - 06/2002
4	Infections 09/2022 - 01/2021
3	Respiratory Tract Infections (Respiratory Tract Infection) 09/2022 - 01/2018
3	Fatigue 01/2022 - 01/2013
2	Common Cold 04/2022 - 03/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
2	Medulloblastoma 02/2020 - 04/2011
2	Rhabdomyosarcoma 02/2020 - 01/2017
2	Bronchitis 01/2019 - 01/2018
1	Fever (Fevers) 09/2022
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Cough 04/2022
1	COVID-19 01/2021
1	Neuroblastoma 02/2020
1	Headache (Headaches) 01/2020
1	Nausea 02/2018
1	Radiodermatitis 02/2018
1	Mucositis 02/2018
1	Vomiting 02/2018
1	Neutropenia 02/2018
1	Rhinosinusitis 01/2018
1	GATA2 Deficiency 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 04/2016
1	Hyperthermia 04/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Weight Loss (Weight Reduction) 01/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 05/2007
1	Astrocytoma (Pilocytic Astrocytoma) 06/2006
1	Sepsis (Septicemia) 06/2006
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 06/2006
1	Cytokine Release Syndrome 06/2006

Drug/Important Bio-Agent (IBA)

4	AcidsIBA 01/2017 - 01/2015
4	TriterpenesIBA 01/2017 - 01/2015
3	EPs 7630IBA 01/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 01/2018
1	Adenosine Monophosphate (AMP)IBA 06/2022
1	Volatile Oils (Essential Oils)IBA 05/2022
1	EA 575 extractIBA 04/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2022
1	Pharmaceutical PreparationsIBA 04/2022
1	Secretory Immunoglobulin A (SIgA)IBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	OsteoprotegerinIBA 01/2018
1	Oleanolic AcidIBA 01/2016
1	mistletoe lectin IIBA 01/2016
1	Cytostatic AgentsIBA 01/2016
1	LectinsIBA 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2009
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2009
1	Plant ExtractsIBA 06/2008
1	Transcription Factors (Transcription Factor)IBA 11/2006
1	Codon (Codons)IBA 11/2006
1	Messenger RNA (mRNA)IBA 01/2006
1	iodoHis(3)- neurokinin A (INKA)IBA 06/2002

Therapy/Procedure

14	Therapeutics 04/2021 - 06/2006
5	Drug Therapy (Chemotherapy) 06/2022 - 06/2006
4	Radiotherapy 01/2022 - 04/2016
1	Hydrotherapy (Whirlpool Bath) 09/2022
1	Aftercare (After-Treatment) 05/2022
1	Aromatherapy 05/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Chemoradiotherapy 04/2011
1	Homeopathy 01/2011